Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1998 3
1999 1
2000 1
2003 3
2004 3
2006 3
2007 2
2008 2
2009 3
2010 10
2011 5
2012 9
2013 12
2014 10
2015 8
2016 8
2017 4
2018 5
2019 10
2020 7
2021 9
2022 6
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
TREM2 triggers microglial density and age-related neuronal loss.
Linnartz-Gerlach B, Bodea LG, Klaus C, Ginolhac A, Halder R, Sinkkonen L, Walter J, Colonna M, Neumann H. Linnartz-Gerlach B, et al. Among authors: klaus c. Glia. 2019 Mar;67(3):539-550. doi: 10.1002/glia.23563. Epub 2018 Dec 11. Glia. 2019. PMID: 30548312 Free PMC article.
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.
Knutson SK, Warholic NM, Wigle TJ, Klaus CR, Allain CJ, Raimondi A, Porter Scott M, Chesworth R, Moyer MP, Copeland RA, Richon VM, Pollock RM, Kuntz KW, Keilhack H. Knutson SK, et al. Among authors: klaus cr. Proc Natl Acad Sci U S A. 2013 May 7;110(19):7922-7. doi: 10.1073/pnas.1303800110. Epub 2013 Apr 25. Proc Natl Acad Sci U S A. 2013. PMID: 23620515 Free PMC article.
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.
Knutson SK, Kawano S, Minoshima Y, Warholic NM, Huang KC, Xiao Y, Kadowaki T, Uesugi M, Kuznetsov G, Kumar N, Wigle TJ, Klaus CR, Allain CJ, Raimondi A, Waters NJ, Smith JJ, Porter-Scott M, Chesworth R, Moyer MP, Copeland RA, Richon VM, Uenaka T, Pollock RM, Kuntz KW, Yokoi A, Keilhack H. Knutson SK, et al. Among authors: klaus cr. Mol Cancer Ther. 2014 Apr;13(4):842-54. doi: 10.1158/1535-7163.MCT-13-0773. Epub 2014 Feb 21. Mol Cancer Ther. 2014. PMID: 24563539
Intestinal barrier: Molecular pathways and modifiers.
Jeon MK, Klaus C, Kaemmerer E, Gassler N. Jeon MK, et al. Among authors: klaus c. World J Gastrointest Pathophysiol. 2013 Nov 15;4(4):94-9. doi: 10.4291/wjgp.v4.i4.94. World J Gastrointest Pathophysiol. 2013. PMID: 24244877 Free PMC article. Review.
[Epidemiology of TBE].
Süss J, Klaus C. Süss J, et al. Among authors: klaus c. MMW Fortschr Med. 2006 Jun 1;148(22):35-9. MMW Fortschr Med. 2006. PMID: 16821579 German.
117 results